Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,111 | -1,429 | -809 | -2,098 | -1,466 |
| Depreciation Amortization | 115 | 75 | 334 | 262 | 173 |
| Accounts receivable | -21 | 158 | -416 | -341 | -176 |
| Other Working Capital | -743 | 177 | -393 | -547 | -275 |
| Other Operating Activity | 748 | 350 | 1,207 | 853 | 586 |
| Operating Cash Flow | $-2,012 | $-669 | $-77 | $-1,871 | $-1,158 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -558 | N/A | 711 | N/A | N/A |
| Debt Issued | 1,187 | 1,187 | N/A | N/A | N/A |
| Debt Repayment | -1,236 | -1,187 | N/A | N/A | N/A |
| Common Stock Issued | 3,916 | 854 | 1,279 | 1,179 | 1,179 |
| Other Financing Activity | 0 | -561 | 0 | 563 | 0 |
| Financing Cash Flow | $3,309 | $293 | $1,990 | $1,742 | $1,179 |
| Exchange Rate Effect | -7 | 1 | 6 | 4 | 5 |
| Beginning Cash Position | 2,194 | 2,194 | 275 | 275 | 275 |
| End Cash Position | 3,484 | 1,819 | 2,194 | 150 | 301 |
| Net Cash Flow | $1,290 | $-375 | $1,919 | $-125 | $26 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,012 | -669 | -77 | -1,871 | -1,158 |
| Free Cash Flow | -2,012 | -669 | -77 | -1,871 | -1,158 |